Skip to main content
Alpfa Medical, Inc.Form D offering

Alpfa Medical, Inc. filed a Form D with the SEC, reporting $80.3M sold, of a $100.3M offering.

What happened

Alpfa Medical is a Palo Alto-based medtech company developing a pulsed field ablation platform for benign prostatic hyperplasia (BPH), a condition that affects millions of men. The company reported a $100.3M Form D offering and had already sold about $80.3M, signaling a well-capitalized healthcare venture with meaningful vendor and partner opportunity.

Source

Also extracted from this source

1 other company
  • Alpfa Medical, Inc.Funding: $80.3M

Extracted by Autobound

From the Signal API record
Signal
Form D offering

What this signalsNew funding often brings new budget and vendor reviews.

Amount
$80.3M
Offering size (USD)
$100M
Industry group
Other Health Care
Headquarters
Palo Alto, CA
Location
PALO ALTO, CALIFORNIA
Filed
Sep 28, 2026

More form D offering signals at other companies

The full record

From the Signal API record

People

  • Allan ZingelerExecutive Officer, Director · Named in the filing
  • David BonitaDirector · Named in the filing
  • Andrew ElBardissiDirector · Named in the filing
  • Michael HurleyDirector · Named in the filing
  • Michael KramerDirector · Named in the filing
  • Raju ViswanathanDirector · Named in the filing
  • Michael WileyExecutive Officer, Director · Named in the filing
  • Rupa PatelExecutive Officer · Named in the filing

Numbers

Amount (USD)
$80.3M
Investors
71
Remaining (USD)
$20M

Details

CIK
0002156252
Form
D
Entity type
Corporation
Jurisdiction
Delaware
Primary topic
Medical Device Fundraise
Revenue range
Decline to Disclose
Business state
CA
Accession number
0001231919-26-001227
Resolved entity type
Operating company
Incorporated
2021
Has non accredited investors
No
Filer
Alpfa Medical, Inc.

Topics and mentions

Topics

  • MedTech
  • BPH
  • Pulsed Field Ablation
  • Clinical Trials
  • Healthcare Growth

Exemptions

  • 06b

Securities

  • Equity
  • Other

Extraction

Confidence
High
Relevance
78%
Detected
Sep 28, 2026
signal_type
sec-form-d-funding
signal_subtype
newFilingCompany

Use this data

Get every form D offering signal for Alpfa Medical, Inc. and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Alpfa Medical, Inc. this week?”

  2. Send it to your own tools

    The Signal API returns form D offering signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-form-d-funding record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/fd-0001231919-26-001227 returns this record as JSON.

{
  "signal_id": "fd-0001231919-26-001227",
  "signal_type": "sec-form-d-funding",
  "signal_subtype": "newFilingCompany",
  "detected_at": "2026-09-28T00:00:00+00:00",
  "company": {
    "name": "Alpfa Medical, Inc.",
    "domain": null
  },
  "data": {
    "cik": "0002156252",
    "phone": "(669) 257-3263",
    "detail": "This size of raise suggests Alpfa Medical is beyond seed stage and likely funding clinical development, regulatory work, and preparation for broader commercialization of its minimally invasive BPH therapy. Vendors should pay attention to spending across clinical trials, device manufacturing, quality/regulatory systems, and commercial infrastructure as the company advances a tissue-selective, no-heat ablation platform.",
    "topics": [
      "MedTech",
      "BPH",
      "Pulsed Field Ablation",
      "Clinical Trials",
      "Healthcare Growth"
    ],
    "summary": "Alpfa Medical is a Palo Alto-based medtech company developing a pulsed field ablation platform for benign prostatic hyperplasia (BPH), a condition that affects millions of men. The company reported a $100.3M Form D offering and had already sold about $80.3M, signaling a well-capitalized healthcare venture with meaningful vendor and partner opportunity.",
    "location": "PALO ALTO, CALIFORNIA",
    "file_date": "2026-09-28",
    "form_type": "D",
    "relevance": 0.78,
    "confidence": "high",
    "exemptions": [
      "06b"
    ],
    "filing_url": "https://www.sec.gov/Archives/edgar/data/2156252/000123191926001227/",
    "source_url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002156252&type=D&dateb=&owner=include&count=40",
    "entity_name": "Alpfa Medical, Inc.",
    "entity_type": "Corporation",
    "jurisdiction": "DELAWARE",
    "primary_topic": "Medical Device Fundraise",
    "revenue_range": "Decline to Disclose",
    "business_state": "CA",
    "industry_group": "Other Health Care",
    "related_persons": [
      {
        "name": "Allan Zingeler",
        "roles": [
          "Executive Officer",
          "Director"
        ]
      },
      {
        "name": "David Bonita",
        "roles": [
          "Director"
        ]
      },
      {
        "name": "Andrew ElBardissi",
        "roles": [
          "Director"
        ]
      },
      {
        "name": "Michael Hurley",
        "roles": [
          "Director"
        ]
      },
      {
        "name": "Michael Kramer",
        "roles": [
          "Director"
        ]
      },
      {
        "name": "Raju Viswanathan",
        "roles": [
          "Director"
        ]
      },
      {
        "name": "Michael Wiley",
        "roles": [
          "Executive Officer",
          "Director"
        ]
      },
      {
        "name": "Rupa Patel",
        "roles": [
          "Executive Officer"
        ]
      }
    ],
    "total_investors": 71,
    "total_remaining": 19999978,
    "accession_number": "0001231919-26-001227",
    "securities_types": [
      "Equity",
      "Other"
    ],
    "business_location": "Palo Alto, CA",
    "total_amount_sold": 80268077,
    "resolved_entity_name": "ALPFA Medical, Inc.",
    "resolved_entity_type": "operating_company",
    "total_offering_amount": 100268055,
    "year_of_incorporation": "2021",
    "company_domain_confidence": 10,
    "has_non_accredited_investors": false
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.